1. ZIX flagship brand - ZIX already contributes 10% of the overall portfolio, making it the single largest identifiable revenue driver. Scaling this brand further directly moves the company's top line without the fixed-cost burden of launching something from zero.
2. Wellness Division geographic expansion - The Wellness Division expanded its general trade footprint from 3 cities to 10 cities during FY24-25, covering Gujarat, Maharashtra, and Karnataka. A 3x increase in city coverage in one year widens the addressable retail base for the newly launched Zixa pain-management products.
3. New pharmaceutical product launches - Powergesic 4X spray and Zixflam Forte tablets were launched in FY24-25, developed by the in-house R&D Centre. New launches in the core pharma division replenish the prescription pipeline and give the recently reorganised NOVA and ZORA field teams fresh detailing ammunition.
4. Wellness Division new product launches - The Wellness Division launched Zixa Ortho Pain Massage Oil and Zixa Multi Action Balm during FY24-25, and introduced affordable SKUs co-developed with physiotherapists. These products create a consumer-health revenue stream outside the prescription channel, with price points designed to pull in first-time users.
5. Pharma division reorganisation into NOVA and ZORA - The pharma division was split into NOVA and ZORA for sharp focus on dedicated brand portfolios. A narrower mandate per team typically lifts sales force productivity, which matters for a company that added over 200 medical education programs in the same year to expand its prescriber base.
6. R&D Centre upgrade - The Shri Hemendra Bhuta Research Centre was redeveloped to international standards and its DSIR recognition was renewed during FY24-25. A compliant, upgraded R&D facility is the prerequisite for developing the next wave of differentiated formulations and for meeting export-market quality requirements.
7. Land acquisition at GIDC-Sihor - On 3 March 2025, the company registered agreements to acquire two adjacent plots totalling 3,160 sq. mtrs. near its existing Sihor plant. Owning adjacent land removes a physical expansion bottleneck and signals that management is preparing for manufacturing scale-up beyond the current CWIP cycle.